InsidersTradesSigma
Browse the full record of transactions filed by Zeldin Robert K, Directeur Médical. Director active across 1 company, notably MeiraGTx Holdings plc. Cumulatively, 1 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €37k. Activity tracked since 3 June 2022. The latest transaction was filed on 3 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration
Robert K. Zeldin is the Chief Medical Officer of MeiraGTx Holdings plc, a biopharmaceutical company specializing in gene therapies. In his role, he is responsible for leading medical initiatives and clinical research programs. Robert brings expertise in medicine and biotechnology, contributing to innovation in the treatment of genetic diseases.